ACS Applied Materials & Interfaces,
Journal Year:
2024,
Volume and Issue:
16(50), P. 69045 - 69054
Published: Dec. 5, 2024
Alzheimer's
disease
(AD)
is
one
of
the
most
common
neurodegenerative
diseases,
commonly
affecting
aged,
with
pathophysiological
changes
presenting
15
to
20
years
before
clinical
symptoms.
Early
diagnosis
and
intervention
are
crucial
in
effectively
slowing
progression
AD.
In
current
study,
poly(2-(methacryloyloxy)ethyl
phosphorylcholine)
(PMPC)-functionalized
NaGdF4
nanoparticles
(NaGdF4-PMPC)
were
developed
as
magnetic
resonance
imaging
(MRI)
contrast
agents
for
targeting
alpha
7
nicotinic
acetylcholine
receptors
(α7
nAChRs)
AD
mice.
NaGdF4-PMPC
showed
excellent
biocompatibility,
ability,
MRI
performance,
longitudinal
molar
relaxivity
(r1)
transverse
(r2)
being
1.21-fold
1.33-fold
higher
than
those
agent
Gd-DTPA,
respectively,
resulting
higher-sensitive
MR
angiography.
After
intravenous
injection,
3D
dynamic
contrast-enhanced
(DCE)
images
high-resolution
vasculature
mouse
brain
obtained.
addition,
by
using
NaGdF4-PMPC,
susceptibility-weighted
(SWI)
signals
brains
greatly
retained
compared
healthy
mice
24
h,
emphasizing
ability
NaGdF4-PMPC.
Furthermore,
CD31,
α7
nAChRs,
Thioflavin
S
staining
also
utilized
investigate
relationship
among
vascular
inflammation,
amyloid-β
(Aβ)
deposition
This
work
highlights
a
promising
targeted
strategy
timely
ACS Applied Materials & Interfaces,
Journal Year:
2024,
Volume and Issue:
16(50), P. 69045 - 69054
Published: Dec. 5, 2024
Alzheimer's
disease
(AD)
is
one
of
the
most
common
neurodegenerative
diseases,
commonly
affecting
aged,
with
pathophysiological
changes
presenting
15
to
20
years
before
clinical
symptoms.
Early
diagnosis
and
intervention
are
crucial
in
effectively
slowing
progression
AD.
In
current
study,
poly(2-(methacryloyloxy)ethyl
phosphorylcholine)
(PMPC)-functionalized
NaGdF4
nanoparticles
(NaGdF4-PMPC)
were
developed
as
magnetic
resonance
imaging
(MRI)
contrast
agents
for
targeting
alpha
7
nicotinic
acetylcholine
receptors
(α7
nAChRs)
AD
mice.
NaGdF4-PMPC
showed
excellent
biocompatibility,
ability,
MRI
performance,
longitudinal
molar
relaxivity
(r1)
transverse
(r2)
being
1.21-fold
1.33-fold
higher
than
those
agent
Gd-DTPA,
respectively,
resulting
higher-sensitive
MR
angiography.
After
intravenous
injection,
3D
dynamic
contrast-enhanced
(DCE)
images
high-resolution
vasculature
mouse
brain
obtained.
addition,
by
using
NaGdF4-PMPC,
susceptibility-weighted
(SWI)
signals
brains
greatly
retained
compared
healthy
mice
24
h,
emphasizing
ability
NaGdF4-PMPC.
Furthermore,
CD31,
α7
nAChRs,
Thioflavin
S
staining
also
utilized
investigate
relationship
among
vascular
inflammation,
amyloid-β
(Aβ)
deposition
This
work
highlights
a
promising
targeted
strategy
timely